NEW YORK, April 25, 2023 (GLOBE NEWSWIRE) -- "Neurological Biomarkers Market" is the latest report from Data Bridge Market Research, offering a comprehensive analysis of growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and the competitive landscape. Neurological Biomarkers business report gives an explanation of the vital developments in the market which range from the crucial improvements of the market, containing research and development, new item dispatch, pronouncement, coordinated efforts, associations, joint aspire, and territorial development of the key rivals working in the market on a global and local scale. Furthermore, the report also estimates essential market features that comprise of revenue (USD), price (USD), capacity utilization rate, production value, production rate, consumption, import-export, supply-demand analysis, cost, market share, gross margin, and market CAGR value. Such a wide range of market parameters makes the global Neurological Biomarkers market research report outperform.
Data Bridge Market Research analyses that the neurological biomarkers market, which was USD 6.92 billion in 2022, would rise to USD 21.45 billion by 2030 and is expected to undergo a CAGR of 13.4% during the forecast period from 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get Access to a Sample PDF of the Neurological Biomarkers Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-neurological-biomarkers-market
Neurological biomarkers are the biomarkers regarded as criteria for evaluating and calculating a method or symptom for acquiring a pharmacological response to a particular treatment. They are widely used for identifying numerous diseases, such as Parkinson's disease, autism, and depression. The common types of neurological biomarkers are imaging, genomics, proteomics, and metabolomics.
As per the WHO, in 2016, epilepsy accounted for about 13 million disability-adjusted life years and more than 0.5% of the global disease burden. This increasing occurrence of neurological disorders can surge the demand for neurological biomarkers as it will help detect the disease. Furthermore, advanced imaging systems are helping in the early diagnosis of various diseases while decreasing the mortality rate.
Opportunities
- Increasing Funds by Market Players
The wide presence of organizations providing funds at numerous stages of research is expected to drive market growth. For instance, the University of North Texas Health Science Center (HSC) was awarded about USD 45.5 million in funds from the National Institutes of Health (NIH) to support research associated with health disparities in Alzheimer's and brain aging. NIH is providing additional funds for biomarkers research for the current Health and Aging Brain Among Latino Elders (HABLE) study. Therefore, this factor boosts the market growth.
The Global Market Is Analyzed in Depth in the Latest Study. Taking into account the current level of competition and its projected evolution over the next few years.
Rapidly increasing demands, a rise in industrialization, consumer awareness, growing sectors, and technical improvements are fueling the expansion of the global Neurological Biomarkers market. Sales and revenue in this sector have increased at an exponential rate. The market's size and growth are both expected to increase thanks to the factors driving the market's expansion over the projected period.
Leading businesses in the Neurological Biomarkers Industry are investing heavily in R&D in order to build a larger client base and expand their share of the market by reintroducing improved products to consumers. All of the companies' strategy, as well as their financial health, revenue, gross margin, and growth rate, are detailed in the study.
Recent Development
- In 2020, Johnson & Johnson Services, Inc. entered into a strategic agreement with Enigma Biomedical Group to assess novel neuroimaging biomarkers-JNJ-64413739 and JNJ-64511070-to understand Alzheimer's disease and other dementias.
Some of the major players operating in the neurological biomarkers market are:
- Thermo Fisher Scientific (U.S.)
- QIAGEN (Netherlands)
- Agilent Technologies, Inc. (U.S.)
- McKesson Corporation (U.S)
- R1 RCM Inc., (U.S)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Bio-Rad Laboratories, Inc. (U.S.)
- BGI (China), Quanterix (U.S.)
- bioMérieux Inc (U.S.)
- Neurosteer Inc. (U.S.)
- Advanced Brain Monitoring, Inc (U.S.)
Download the Complete Research Study Here in PDF Format @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-neurological-biomarkers-market
The investment made in the study would provide you access to information such as:
- Neurological Biomarkers Market [Global – Broken-down into regions]
- Regional level split [North America, Europe, Asia Pacific, South America, Middle East & Africa]
- Country-wise Market Size Split [of important countries with major market share]
- Market Share and Revenue/Sales by leading players
- Market Trends – Emerging Technologies/products/start-ups, PESTEL Analysis, SWOT Analysis, Porter’s Five Forces, etc.
- Neurological Biomarkers Market Size
- Market Size by Application/industry verticals
- Market Projections/Forecast
Key Industry Drivers:
- Increasing Technological Advancements by Market Players
Recent advancements in biomarkers, such as biomarker signatures, make neurological diseases more treatable. This has resulted in faster drug development, noninvasive testing, and early diagnosis. Additionally, digital biomarkers offer numerous pharmaceutical companies with supplemental information to conclude clinical trial decisions. The National Institute of Neurological Disorders and Stroke provides funding, such as development grants and cooperative agreements, for researchers performing studies associated with biomarker discovery, analytical validation, and clinical validation. Thus, this factor boosts market growth.
- Increasing Development of Precision Medicine
Biomarker research in neurodegenerative disease is a huge advancing area in personalized medicine. Many molecules have been assessed and associated with varied neurodegenerative disorders. This evolution within precision medicine has impacted the biopharmaceutical industry. Different players, from biopharma to diagnostics companies with several functions, such as research and development to commercial operations, will observe a huge change. This is anticipated to impact the market growth positively.
Explore More Detailed about This Study @ https://www.databridgemarketresearch.com/reports/global-neurological-biomarkers-market
Neurological Biomarkers Segmentation:
Product Type
- Proteomics Biomarker
- Imaging Biomarker
- Metabolomics Biomarker
Indication
- Spinal Muscular Atrophy
- Parkinson's Disease
- Schizophrenia
- Huntington's Disease
- Alzheimer's Disease
- Depression
- Multiple Sclerosis
Imaging Techniques
- Transcranial Magnetic Stimulation
- Diffusion Tensor Imaging
- Conventional Structural MRI
- Functional Magnetic Resonance Imaging
- Positron Emission Tomography
Services
- Sample Preparation
- Assay Development
- Biomarker Validation and Testing
End User
- Clinical Diagnostics
- Pharmaceutical And Biotechnology Companies
- Research Organizations
Neurological Biomarkers Market Regional Analysis/Insights:
The countries covered in the neurological biomarkers market report are the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the neurological biomarkers market because of the increase in healthcare expenditure and huge commercial performances of neurological diagnostics in the U.S. Furthermore, the growing product launches combined with the increase in demand for biomarkers are anticipated to impact the regional market positively.
Asia-Pacific is expected to witness significant growth because of the region's improvement in healthcare infrastructure and increase in disposable income. Also, an increasing number of clinical trials being performed in emerging countries, such as India and China, leads to market growth.
Core Objective of Neurological Biomarkers Market:
Every firm in the Neurological Biomarkers market has objectives but this market research report focus on the crucial objectives, so you can analysis about competition, future market, new products, and informative data that can raise your sales volume exponentially.
- Size of the Neurological Biomarkers market and growth rate factors.
- Important changes in the future Neurological Biomarkers Market.
- Top worldwide competitors of the Market.
- Scope and product outlook of Neurological Biomarkers Market.
- Developing regions with potential growth in the future.
- Tough Challenges and risk faced in Market.
- Global Neurological Biomarkers top players profile and sales statistics.
Table of Contents:
- Introduction
- Market Segmentation
- Executive Summary
- Premium Insights
- Global Neurological Biomarkers Market: Regulations
- Market Overview
- Global Neurological Biomarkers Market, By Product Type
- Global Neurological Biomarkers Market, By Indication
- Global Neurological Biomarkers Market, By Imaging Techniques
- Global Neurological Biomarkers Market, By Services
- Global Neurological Biomarkers Market, By End User
- Global Neurological Biomarkers Market, By Region
- Global Neurological Biomarkers Market: Company Landscape
- SWOT Analyses
- Company Profile
- Questionnaires
- Related Reports
Download the Complete Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-neurological-biomarkers-market
Explore More Reports:
- Biomarkers Market, By Type (Safety, Efficacy, Validation), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease-Risk Assessment, Others), Product Type (Consumables, Services, Software), Technology (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others) https://www.databridgemarketresearch.com/reports/global-biomarkers-market
- Biomarkers Market, By Type (Safety, Efficacy, Validation), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease-Risk Assessment, Others), Product Type (Consumables, Services, Software), Technology (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others) https://www.databridgemarketresearch.com/reports/global-biomarkers-market
- Cancer Biomarkers Market, By Product (Consumables, Services, Software, Growth Hormone Therapy), Type (Safety, Efficacy, Validation, Protein, Pharmacodynamics, Genetic), Technology (OMICS, Imaging Technology, Immunoassays, Cytogenetics, and Bioinformatics), Service (Sample Preparation, Assay Development, Biomarkers, and Testing), Application (Diagnostics Development, Drug Discovery, and Development, Personalized Medicine, Disease-Risk Assessment, Others), Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Other Diseases), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others) https://www.databridgemarketresearch.com/reports/global-cancer-biomarkers-market
- Rare Biomarkers Market, By Product (Circulating Cell Free DNA, Circulating Tumor Cells, Exosomes/Extracellular Vesicles, Circulating Cell Free RNA, and Others), End Use (Research, and Diagnostics) https://www.databridgemarketresearch.com/reports/global-rare-biomarkers-market
- Rare Biomarkers Specimen Collection and Stabilization Market, By Type (Circulating Cell Free DNA (ccfDNA), Circulating Tumor Cells (CTCs), Exosomes/Extracellular Vesicles), Product (Isolation Kits and Reagents, Blood Collection Tubes, and Systems), Specimen (Serum/Plasma, Others), Nucleic Acid and Other Biomolecules (RNA, DNA, Others), Application (NIPT, Oncology, Transcriptomics, Pharmacogenomics, Transplant Rejection, Population Screening, Cardiovascular Diseases, Others), End Use (Hospitals, Perinatal Clinics, Public Health Labs, Private or Commercial Labs, Physician Labs, Research Institutes, Others) https://www.databridgemarketresearch.com/reports/global-rare-biomarkers-specimen-collection-and-stabilization-market
- North America Biomarkers Market, By Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarker), Product (Consumables, Services, Software, Growth Hormone Therapy), Mechanism (Genetic, Epigenetic, Proteomic, Lipidomic, and Other Mechanisms), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease Risk Assessment, Others), Disease Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others), Country (U.S., Canada, Mexico, Germany) https://www.databridgemarketresearch.com/reports/north-america-biomarkers-market
- North America Cancer Biomarkers Market, By Type (Genetic Biomarkers, Protein Biomarkers, Other Cancer Biomarkers), Product (PSA, HER-2, EGFR, KRAS, Others), Cancer (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Melanoma, Ovarian Cancer, Liver Cancer, Stomach Cancer, Others), Technology (Imaging Technologies, Omic Technologies, Cytogenetic-Based Tests and Immunoassays), Applications (Drug Discovery and Development, Personalized Medicine, Diagnostics and Others), End User (Hospitals, Academic and Cancer Research Institutes, Ambulatory Surgical Centers and Diagnostic Laboratories), Country (U.S., Canada, Mexico) https://www.databridgemarketresearch.com/reports/north-america-cancer-biomarkers-market
- Europe Cancer Biomarkers Market, By Product (Consumables, Services, Software, Growth Hormone Therapy), Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, Protein Biomarkers, Pharmacodynamics Biomarkers, Genetic Biomarkers), Profiling Technologies (OMICS, Imaging Technology, Immunoassays, Cytogenetics and Bioinformatics), Service (Sample Preparation, Assay Development, Biomarkers and Testing), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease-Risk Assessment, Others), Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Other Diseases), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others) https://www.databridgemarketresearch.com/reports/europe-cancer-biomarkers-market
- Europe Biomarkers Market, By Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarker), Product (Consumables, Services, Software, Growth Hormone Therapy), Mechanism (Genetic, Epigenetic, Proteomic, Lipidomic, and Other Mechanisms), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease Risk Assessment, Others), Disease Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others) https://www.databridgemarketresearch.com/reports/europe-biomarkers-market
- Neurological Monitors Market, By Product Type (Magnetic Resonance Imaging (MRI) Devices, Electroencephalography Devices, Cerebral Oximeters, Intracranial Pressure Monitors, Others), Disease Type (Traumatic Brain Injury (TBI), Stroke, Sleep Disorders, Parkinson's Disease, Epilepsy, Other Diseases), Application (Monitors of Intracranial Pressure and Blood Flow Dynamics, Monitors of Brain Electrical Activity), Procedure (Invasive, Non-Invasive), End User (Healthcare Institutions, Diagnostic Centers and Research Institutes) https://www.databridgemarketresearch.com/reports/global-neurological-monitors-market
- Neurological Disorder Drugs Market, By Indication (Epilepsy, Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Cerebrovascular Disease, Others), Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) https://www.databridgemarketresearch.com/reports/global-neurological-disorder-drugs-market
About Data Bridge Market Research:
An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
